S&P 500
5,940.46
-0.4%
-23.14
DJI
42,677.24
-0.3%
-114.83
NASDAQ
$19,142.71
-0.4%
-$72.75
Bitcoin
107,263.00
+1.6%
+1,680.87
AAPL
$206.73
-1.0%
-$2.05
AMZN
$204.08
-1.0%
-$2.08
GOOG
$165.14
-1.6%
-$2.73
META
$636.43
-0.6%
-$4.00
MSFT
$457.90
-0.2%
-$0.97
NVDA
$134.22
-1.0%
-$1.34
TSLA
$343.52
+0.4%
+$1.43
Clover (ASX: CLV)
A$0.46
(-2.1%)
-A$0.01
Price as of May 21, 2025, 1:20 a.m. ET
Clover Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Clover Company Info
Clover Corp. Ltd. is engaged in research and product development of food supplements, pharmaceutical and nutraceuticals. The company focuses on the delivery of bioactive ingredients using proprietary encapsulation technology to produce ready-to-blend products containing tuna oil and other nutritional lipids. Its products include Docosahexaenoic acid oils & powders and Microencapsulation. The company was founded by Guy Hamish Drummond in 1988 and is headquartered in Sydney, Australia.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.